Access one of the largest hepatocyte, tissue fraction, and recombinant enzyme inventories in the world accompanied by leading-edge service techniques.
A technology agnostic approach to enable an unbiased selection of the most suitable platforms.
We provide direct access to our highly-experienced scientists who can consult on the project design to ensure the production of meaningful, relevant data on the drug candidate.
Specialty testing in CLIA-certified, CAP accredited, and GCLP compliant service laboratories to support downstream clinical trials and regulatory submissions.
Decades of experience progressing preclinical and translational studies to later stages of development.
Join Discovery Life Sciences at Phacilitate's Advanced Therapies Week 2025, Jan 20-23 in Dallas! Visit us at Booth 161 and join Dr. Yuki Maves' presentation on Jan 23. Supply Chain: […]
Join Discovery at Precision Medicine Tri-Con 2025.
Join Discovery at World CB & CDx Summit Europe 2025.
Copyright © 2024 Discovery Life Sciences. All rights reserved.
Designed & Developed by Altitude Marketing
